Trump Considers Tapping US Oil Reserve

US President Donald Trump speaks during a joint news conference with Japan's Prime Minister Shinzo Abe at Trump's Mar-a-Lago estate in Palm Beach, Florida, US, April 18, 2018. REUTERS/Kevin Lamarque
US President Donald Trump speaks during a joint news conference with Japan's Prime Minister Shinzo Abe at Trump's Mar-a-Lago estate in Palm Beach, Florida, US, April 18, 2018. REUTERS/Kevin Lamarque
TT

Trump Considers Tapping US Oil Reserve

US President Donald Trump speaks during a joint news conference with Japan's Prime Minister Shinzo Abe at Trump's Mar-a-Lago estate in Palm Beach, Florida, US, April 18, 2018. REUTERS/Kevin Lamarque
US President Donald Trump speaks during a joint news conference with Japan's Prime Minister Shinzo Abe at Trump's Mar-a-Lago estate in Palm Beach, Florida, US, April 18, 2018. REUTERS/Kevin Lamarque

The Trump administration is actively considering tapping into the nation’s emergency supply of crude oil as political pressure grows to rein in rising gasoline prices before congressional elections in November, two people familiar with the situation told Bloomberg.

No decision has been made to release crude from the 660-million-barrel stockpile, known as the Strategic Petroleum Reserve, but options under review range from a 5-million-barrel test sale to release of 30 million barrels, said the people, who requested anonymity to discuss non-public deliberations.

An even larger release is possible if were to be coordinated with other nations, Bloomberg said.

The national unleaded average gasoline price rose to $2.89 Friday, up 63 cents or 28 percent from a year ago, according to data from AAA. The US gasoline price average is expected to range between $2.85 per gallon and $3.05 per gallon through Labor Day, according to the group.

And as average prices close in on $3 a gallon -- they’re well above that in many locations -- Trump hasn’t been shy about voicing his displeasure.

“Oil prices are too high, OPEC is at it again. Not good!” he said on Twitter in June. He also said: “REDUCE PRICING NOW!”

Meanwhile, a senior Iranian oil official urged Trump not to use the nation’s Strategic Petroleum Reserve to push prices lower, and instead drop sanctions on Iran’s crude exports.

“My advice to you, Mr. President, is to avoid touching the SPR - to cool down and give up sanctioning Iranian oil," Hossein Kazempour Ardebili, Iran’s representative to OPEC, said by email to Bloomberg.



UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
TT

UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM

Mubadala Investment Company has acquired an 80% stake in Global Medical Supply Chain (GMSC) and Al Ittihad Drug Store (IDS) from GlobalOne Healthcare Holding (GHH), with GHH retaining a 20% stake, Emirates News Agency (WAM) reported on Tuesday.

This strategic acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors, aligning with the UAE's vision to establish a robust life sciences infrastructure, WAM said.

Founded in 2015, GMSC provides comprehensive end-to-end supply chain services for medical products, including demand planning, procurement, logistics, inventory management, warehousing, and maintenance.

GMSC serves over 200 medical facilities, including hospitals and clinics across the UAE. With a dedicated team of medical supply chain specialists, GMSC sources a broad array of products from almost 400 suppliers, ensuring a reliable supply chain for all medical needs.

IDS, established in 1987, stands as one of the leading distributors of pharmaceutical and consumer healthcare products in the UAE. Distributing over 1,000 products from over 40 leading suppliers, IDS services every hospital, and all, or at least most pharmacies and supermarkets within the UAE. It boasts a vast portfolio that spans multiple therapeutic categories including anti-infectives, asthma, diabetes, and oncology.

"The expanding pharmaceutical market drives an increasing demand for specialized and efficient drug logistics solutions. By integrating GMSC and IDS into our portfolio, we are poised to create a vertically integrated life sciences sector in the UAE and enable its potential to encompass the entire value chain from logistics and distribution to specialized manufacturing,” said Executive Director of UAE Clusters at Mubadala's UAE Investments Platform Ismail Ali Abdulla.

As for Low Ping, Group CEO Yas Holding, she said that the transaction “continues Mubadala's strategic growth, following another significant acquisition by its new speciality pharmaceutical business, KELIX bio, which recently acquired a 100% stake in four pharma assets from GlobalOne Healthcare Holding's, the healthcare division of Yas Holding.”

“These concerted efforts underline Mubadala's commitment to strengthening the UAE's healthcare and pharmaceutical sectors as part of broader national ambitions for drug security and economic diversification."

GlobalOne Healthcare Holding LLC serves as the dedicated Healthcare Division of Yas Holding LLC, focusing on enhancing healthcare outcomes by investing in innovative solutions across various healthcare verticals.